Moderna | MRNA - Ordinary Share Capital


Moderna reported $391M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 169.18M 470K Dec/2025
Agios Pharmaceuticals USD 59.34M 892K Mar/2026
Alnylam Pharmaceuticals USD 133.44M 1.07M Mar/2026
Amgen USD 540M 1000K Mar/2026
Arrowhead Research USD 137.39M 1.69M Dec/2025
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 193.27M 969K Mar/2026
Celltrion KRW 218.61M 162.21K Dec/2025
Cspc Pharmaceutical CNY 11.52B 3.7M Dec/2025
Deva Holding AS TRY 200.02M 0 Sep/2023
Dianthus Therapeutics USD 43.22M 368.53K Dec/2025
Divis Laboratories Ltd INR 265.47M 0 Mar/2026
Esperion Therapeutics USD 245.22M 39.79M Dec/2025
Gilead Sciences USD 1.24B 1000K Mar/2026
GlaxoSmithKline GBP 4.05B 20.6M Mar/2026
Incyte USD 199.95M 1.49M Mar/2026
Ionis Pharmaceuticals USD 165.9M 3.93M Mar/2026
Kangmei Pharma CNY 13.83B 0 Mar/2026
Knight Therapeutics CAD 99.68M 24.66K Sep/2025
Laboratorios Farma EUR 51.82M 1.55M Dec/2023
Malin Corporation EUR 200K 0 Dec/2024
Moderna USD 391M 2M Sep/2025
Organigram Holdings CAD 135.13M 671.75K Dec/2025
Ovoca Bio EUR 29.49M 18.43M Jun/2025
Pharma Mar EUR 17.36M 0 Mar/2026
Puma Biotechnology USD 5K 0 Jun/2024
Qiagen NV USD 216.56M 284.67K Dec/2025
Regeneron Pharmaceuticals USD 105M 300K Mar/2026
Sarepta Therapeutics USD 105.57M 607K Mar/2026
Sartorius EUR 69.05M 0 Mar/2026
Sino Biopharmaceutical CNY 17.89B 30.5M Jun/2025
Tilray USD 116.52M 5.01M Sep/2025
Ultragenyx Pharmaceutical USD 98.3M 1.7M Mar/2026
United Therapeutics USD 42.16M 1.49M Mar/2026
Vertex Pharmaceuticals USD 254.2M 200K Mar/2026
Zealand Pharma A/S 70.61M 319.68K Dec/2025
Zz Pientze Pharmaceu CNY 603.32M 0 Mar/2026